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Abstract
Purpose Computer algorithms and Machine Learning (ML) will be integrated into clinical decision support within occu-
pational health care. This will change the interaction between health care professionals and their clients, with unknown 
consequences. The aim of this study was to explore ethical considerations and potential consequences of using ML based 
decision support tools (DSTs) in the context of occupational health. Methods We conducted an ethical deliberation. This was 
supported by a narrative literature review of publications about ML and DSTs in occupational health and by an assessment of 
the potential impact of ML-DSTs according to frameworks from medical ethics and philosophy of technology. We introduce 
a hypothetical clinical scenario from a workers’ health assessment to reflect on biomedical ethical principles: respect for 
autonomy, beneficence, non-maleficence and justice. Results Respect for autonomy is affected by uncertainty about what 
future consequences the worker is consenting to as a result of the fluctuating nature of ML-DSTs and validity evidence used 
to inform the worker. A beneficent advisory process is influenced because the three elements of evidence based practice are 
affected through use of a ML-DST. The principle of non-maleficence is challenged by the balance between group-level ben-
efits and individual harm, the vulnerability of the worker in the occupational context, and the possibility of function creep. 
Justice might be empowered when the ML-DST is valid, but profiling and discrimination are potential risks. Conclusions 
Implications of ethical considerations have been described for the socially responsible design of ML-DSTs. Three recom-
mendations were provided to minimize undesirable adverse effects of the development and implementation of ML-DSTs.
Keywords Machine learning · Clinical decision support system · Occupational health · Ethics · Morals · Evidence based 
practice
Introduction
Machine Learning (ML) techniques have become part of our 
daily lives, with examples such as tailored online shopping 
on Amazon or the social fitness network STRAVA (www.
strav a.com) which is fully supported by algorithms to track 
and share cycling and running exercises. The introduction 
of ML for occupational health care seems inevitable [1, 2]. 
An insight from the philosophy of technology is that new 
technologies change our behaviours and our understanding 
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of the world around us [3]. Implementation of an ML-based 
Decision Support Tool (ML-DST) could drastically change 
the way occupational health care providers (OHCP) work, 
make decisions, and interact with clients. It also has impli-
cations for how OHCP and their clients perceive and value 
the changes.
The clinical scenario in Table 1 about ML for decision 
support in preventive occupational health care raises ques-
tions such as, “how will ML influence health-related choices 
of the worker?” and “will the ML technique result in dis-
crimination?”. In philosophical and ethical approaches to 
technology assessment, it is proposed that scenarios are a 
good way to explore the soft impact (i.e. impact that cannot 
be quantified) of technology before it is fully functional [4, 
5]. It helps to anticipate possible adverse effects with ethical 
implications and therefore allows for more socially responsi-
ble innovation [6, 7]. As ML-DSTs are being developed for 
use in health care settings, it seems appropriate to refer to the 
four pre-dominating biomedical ethical principles presented 
by Beauchamp and Childress [8]: respect for autonomy, jus-
tice, beneficence and non-maleficence.
The aim of this study is to explore potential consequences 
and ethical considerations of using ML-DSTs in the context 
of occupational health. These insights raise awareness for 
users (OHCPs) as well as technology developers and guiding 
points to consider during responsible design of ML-DSTs. 
The ethical deliberation is elaborated using our example 
from the context of health prevention, namely a workers’ 
health assessment (WHA) done periodically to predict the 
workers’ likelihood of developing a health disorder. How-
ever, the ethical issues discussed apply equally to other occu-
pational health-related procedures, such as return to work 
assessments or rehabilitation interventions [2, 9].
Methods
Study Design
We conducted an ethical deliberation. This was supported by 
a narrative literature review of publications about ML-DSTs 
and by an assessment of the impact of ML-DSTs according 
to frameworks from medical ethics [8] and the philosophy 
of technology [5, 10–12].
Literature Review
A narrative literature review was conducted focusing on eth-
ical considerations of using ML techniques for decision sup-
port in health care settings. Relevant terms and definitions 
used to indicate the field were searched for using library 
health databases (PubMed and Medline) and Google Scholar 
[13]. Search terms included: big data analyses, machine 
learning techniques, artificial intelligence and machine intel-
ligence in combination with decision support, health and 
ethics. A snowball method was used after the first search.
Ethical Principles and Impact Assessment
Most ML-related literature is not specifically focused on 
occupational health. Therefore, knowledge from the fields 
of technology assessment and moral philosophy of tech-
nology [5, 10–12] was applied to consider the impact and 
potential adverse effects of ML in the occupational context. 
We focused on concepts used explicitly and implicitly in the 
available texts, such as adverse effects (negative side effects), 
behaviour steering, and views on technology. Moreover, we 
reflected on the widely accepted four major values in bio-
medical ethics as formulated by Beauchamp and Childress 
[8]: respect for autonomy, beneficence, non-maleficence and 
Table 1  Clinical scenario
Tom (54 years old, team-leader at a car plant) wants to improve his health because he feels tired and has gained too much weight lately. His 
employer wants to support him so he can be more productive and efficient in both future work and private life. An Occupational Health Care 
Professional (OHCP) is hired by the company to advise employees on strategies for achieving sustainable employment. Tom consults the 
OHCP. After Tom completes an occupational health assessment, the OHCP prints a list of potential interventions from a computer and reads 
it to Tom. The advice was generated by a Decision Support Tool that is based on data of many employees from a variety of companies. The 
Decision Support Tool uses Machine Learning algorithms for decision making. Tom feels aversion that the computer tells him what to do 
and resistant to the recommended mental health intervention; “I am not mentally ill, I just feel a bit tired of the recent reorganization”. Now 
Tom becomes afraid of what the outcome will mean for his function and employment in the company. Due to a precarious financial position 
the company is very selective about who they employ and Tom thinks mental health issues could implicate job vulnerability. Besides, how 
will the insurance company act when they find out? On the other side of the table, the OHCP is also surprised by the proposed mental health 
interventions; based on his conversation with Tom and his professional intuition, he would have proposed something different. He does agree 
with the advised physical training program and dietary intervention. The OHCP wonders if he should convince Tom, because motivating 
clients towards a healthier lifestyle is one of the OHCP’s competences. Before that, he would need to convince himself that the advice is 
correct. When Tom returns to the work-floor he talks to his colleague Jack about the algorithm-based diagnosis and recommendations. Jack 
is upset because he assumes that his own assessment results could have been used for the algorithm and this is not what he wanted when he 
agreed to use his data for scientific purposes. However, the assessment had a positive effect on his own health and he has remained employed 
largely because of it
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justice. The values are defined and explained in Table 2. 
These are the predominant values in western society [14] 
and might be affected by using DSTs.
Examples Used for the Deliberation
The clinical scenario is used as an example for the ethical 
considerations [4, 5, 12]. WHA and ML are now briefly 
explained, because this provides essential context to the 
scenario. The ethical consequences of using an ML-DST 
are considered primarily from the worker’s perspective. 
However, the professional’s perspective and developmental 
aspects that effect responsible use are also considered.
Worker’s Health Assessment (WHA)
A WHA is a screen by an OHCP to identify health risks in 
order to prevent absenteeism, presenteeism, and promote 
sustained employability [16–19]. With regard to prevention 
of health conditions that influence work ability, evidence-
based resources have been implemented into periodic WHAs 
[16, 20]. Within WHAs, biometrics (e.g., blood-pressure, 
cholesterol, glucose, Body Mass Index, waist circumfer-
ence), functional capacity measurements, and questionnaires 
measuring relevant constructs (e.g., workability, engage-
ment, vitality, mental and physical stress and strain, health 
status, lifestyle) may be administered for health and work-
related risk assessments. After the assessment, the OHCP 
provides personalized advice and recommendations for 
interventions, if applicable. The employer may be informed 
on anonymous group level about the results, but individual 
worker results and recommendations are typically not shared 
with employers. Often various health-related interventions 
are recommended.
Machine Learning (ML) and Data Handling
ML has potential for designing improved DSTs for sustained 
employability and is an analytical solution to overcome the 
limitations of traditional best evidence approaches [21–23]: 
combining different types of measures, pattern recognition, 
processing large volumes of data, and learning during the 
process [13].
In the introduction of his special series [13] the authors 
describe ML as focusing “on optimizing relevant perfor-
mance metrics via learning on a training set and testing on a 
validation set. In this set up, the performance of the predic-
tive models takes precedence over understanding the rela-
tionship between dependent variables and the independent 
variables”. ML is performed on large amounts of data which 
reduces likelihood of errors of estimation and measurement. 
With correlation-based methods, ML aims to reveal patterns 
instead of causality in “real world data” [23]. For DSTs, 
profiling data of persons, data of the followed interventions, 
and data indicating the outcome variable serve as the train-
ing set and the validation set. With an algorithmic approach, 
the DST learns what works for whom. After the algorithm 
is trained and validated, the DST is implemented in regular 
service and individual determinants (the profile) can serve 
as input. Then, the output of the DST is a recommenda-
tion for an intervention. The validation set and training set 
are usually independent, but are often a selected part of the 
same large dataset [1, 2]. We refer to the introduction of 
this special series for a more detailed definition and expla-
nation of ML and the main differences with conventional 
statistical methods [13]. In brief, “many ML algorithms 
are adopted from the statistics literature, and a number of 
Bayesian methods have been incorporated. ML usually does 
not attempt to isolate the effect of any single variable, but 
is concerned with building an empirical algorithm for pur-
poses of prediction or classification. ML approaches include 
random forests, recursive partitioning (CART) and decision 
trees, bagging, boosting, support vector machines, neural 
networks, deep learning, and others. Many ML approaches 
do not model the data generating process but rather attempt 
to learn from the dataset at hand” [13].
In our clinical example, data for development of the 
ML algorithm were obtained from workers at a variety of 
Table 2  The four predominating biomedical ethical principles by Beauchamp and Childress [8]
Respect for autonomy addresses the duty for a professional to respect someone’s decision-making capacity and enabling individuals to make 
reasoned informed choices. In practice this means that the professional has to reduce limiting factors in decision making. In a more positive 
way this means that there is an obligation to disclose information, giving options and helping individuals gain understanding. There is also 
the obligation to respect a decision once it is made
Beneficence is the principle of acting with the best interest of the other in mind. More specifically, within healthcare settings, the health care 
professional should act in a way that benefits the client. Examples are promoting health, reducing risks and preventing health issues and 
disease. The principle also considers balancing the benefits of interventions against risks and costs
Non-maleficence is the principle of “above all, do no harm”. Harm is not just inflicting physical or mental pain and suffering, but can also be 
seen as going against one’s needs and interests. Although all treatment involves some potential for harm, the harm should be proportionate to 
the benefit of the treatment
Justice, which can be divided into: (1) justice as equality regarding benefits, risks and costs; and (2) justice as a fair distribution of rights and 
duties [15]. Specifically this means that a health professional has the obligation to be unbiased
 Journal of Occupational Rehabilitation
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companies during care as usual. Data were collected by 
OHCPs that work for an Occupational Health Service com-
pany. With respect for privacy and consent, the ML-DST is 
developed in co-operation with the Occupational Health Ser-
vice and research institutions. Data are provided to the ML 
algorithms as a training-set and a validation-set, predicting 
suitable interventions to maintain sustained employability 
as the outcome. After implementation, the ML-DST will 
continue to develop because it is a learning system where 
new collected data can constantly be used to train the system 
and provide more detailed predictions for sustained employ-
ability due to the techniques that are used.
Results
Improving sustainable employment of workers with an effi-
cient, valid support for clinical decision making for use by 
OHCPs is the reason for developing ML-DSTs with the best 
available techniques. The ML-DST will induce a change in 
behaviour and perceptions of stakeholders involved [3, 4, 
10]. The ethical issues that emerge are sometimes unique to 
the new technology, but can also be inherent to an advisory 
process in general. For example, privacy has always been an 
issue in using and developing DSTs with conventional meth-
ods and statistics. We have described and discussed results 
with a focus on the changes that occur as a result of the 
new technology and what this means for autonomy, benefi-
cence, non-maleficence and justice. First, we describe what 
implications the scenario have for Tom according to the ethi-
cal principles. Next, we explain the issues that specifically 
emerge when using the new technology and how they relate 
to the ethical principles. For each ethical principle we close 
with the consequences and possible directions for stakehold-
ers and developers. Table 3 provides an explanation of the 
key issues identified in the literature and summarizes their 
relation to the four basic ethical principles.
Respect for Autonomy
Clinical Scenario
Tom makes his own autonomous decision to improve his 
health. However, Tom feels resistance to the digitized pro-
cess and the outcome. He does not want to be pushed in a 
direction he does not feel comfortable with and he wants 
to be able to refuse the intervention. A precondition for an 
autonomous choice is that the choice is well-informed, but 
both the OHCP and Tom are insecure about the quality of 
the advice.
Issues Discussed: Consent, Verifiability and Validity of Data
To respect Tom’s autonomy, he should have free choice. 
But a potential adverse effect of the digitized process might 
be that Tom feels forced into treatment options, which 
affects his autonomy and personal freedom. Consent is an 
important principle for protection of this aspect of auton-
omy, and is partly governed by law [20, 30] and partly by 
scientific ethical standards [25, 31, 32]. According to the 
Declaration of Helsinki, health sciences researchers are 
required to explain the research to participants in a man-
ner they can understand. Informed consent is required for 
most studies involving human participants, however, may 
be waived in some situations involving health registries, 
large databases, or data gathered as part of care as usual 
in some jurisdictions. In Tom’s case the development of 
the ML-DST for a WHA used data gathered as part of 
care as usual and the study was waived by the medical 
ethical committee. Nevertheless, workers included in the 
development process signed an open consent [22], mean-
ing they agreed that their data could be used for scientific 
purposes to improve the health service without specifying 
the use and they can withdraw whenever they want. In this 
case, Tom provided consent but it may be unclear if he 
understood what he consented to. A major difference for 
ML-based decision support is that the technique is flexible 
by nature and after initial development the algorithms are 
regularly updated with new sets of data. The algorithm 
structure can be adjusted over the course of time to address 
new emerging themes. Especially when the phase of devel-
opment fades into implementation of the ML-DST as part 
of usual care, modifications might no longer be registered. 
Additionally, the analytic process and the inferred classifi-
cation model underlying recommendations often become 
non-transparent and non-verifiable.
Another important part of an autonomous choice is that 
the worker is well informed. Tom should be able to rely on 
the professional’s advice as valid and accurate. There are 
two aspects to address. First, the objective quality of the 
ML-DST output and second the advice given by the pro-
fessional. This last aspect will be covered in the paragraph 
“beneficence”, the objective quality of the ML-DST output 
will be explored in the following paragraphs.
Validity of research indicates the extent to which results 
are representative, accurate, and reliable for the group and 
for the purpose studied. Verifiability of data is a prerequi-
site for reliability. ML has the potential to provide better 
information for decision making than traditional special-
ists, reducing the likelihood of human error, and increasing 
external validity [21, 23]. This would be a great benefit for 
all potential users of ML-DSTs. Reasons provided for bet-
ter classification and prediction are the large amount of data 
the outcome is based on that reduces likelihood of errors 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Journal of Occupational Rehabilitation
1 3
of estimation and measurement, the advanced techniques 
used, the shift from causality based research to correlation 
based research revealing patterns that people often are not 
aware of, and the use of “real world” data instead of con-
trolled data from clinical study designs [23]. Each of these 
theoretically contribute to providing a better picture of the 
real situation, which is one of the main reasons to use ML 
techniques. The validity of the advice and recommendations 
made would improve, which would contribute to Tom’s 
health and wellbeing.
Unfortunately, the positive idea that real world data 
informs development of ML-DSTs to provide improved 
validity should be tempered by the knowledge that the output 
of ML algorithms depend on the choices made for input-data 
and algorithms used [9, 33]. Achieving valid and replica-
ble classification models is currently challenging [9], and 
algorithms may not be as valid as hoped for. Often models 
are theory-based or made and constrained by humans who 
do not necessarily have (bio-)medical knowledge [21, 34]. 
Beyond this, the technical choices in deep learning methods 
have a black box character and are not transparent. Often the 
decision paths are too complex to be understood by humans 
[34]. Although deep learning methods often provide better 
accuracy [13], findings could emerge that are not directly 
related to the study and clinical significance of findings 
is not always obvious [22]. A consequence of this lack of 
verifiability or transparency is that results may be invalid 
without users even being aware.
Consequences and Directions for Stakeholders 
and Development
Participants have the right that any consent they provide 
represents an informed choice, and therefore, they should be 
informed about future use and consequences of the process-
ing of their data by researchers and users (e.g., OHCPs) [28]. 
The application of ML-techniques simplifies adjustments 
to algorithms and can allow the original purpose of data 
gathering to be changed. When assessing a research applica-
tion, Health Research Ethics Committees should be aware of 
and address possible changes of the ML-DST characteristics 
(e.g., input parameters, algorithm) after the developmen-
tal phase. To our knowledge there is increasing awareness 
and guidelines are being developed [28], but a standardized 
approach to ethical approval and oversight has not yet been 
specified for all Ethics Committees yet.
While using ML-DSTs, respect for autonomy requires 
disclosure of information that is valid, reliable and trans-
parent. ML techniques are theoretically able to provide bet-
ter predictions than humans or traditional statistical meth-
ods, and are therefore essentially a positive contribution to 
a well-informed decision. However, this is not always the 


















































































































































































































































































































































































































































































































































































































































































































































































































































































Journal of Occupational Rehabilitation 
1 3
of replication were unfavorable. A change in context (e.g., 
insurance policy or legislation) might dramatically influence 
the validity of results. Although this could be corrected over 
time when feedback loops suggest that previous recommen-
dations are not successful anymore, it might also be neces-
sary to include new parameters as input. As mentioned in the 
method section, the validation dataset used for development 
is often part of a large dataset. Validation outside the pri-
mary development dataset would improve knowledge about 
external validity. This indicates the importance for experts 
from the various domains to collaborate, whereby the medi-
cal experts can ensure that the input is correct and that the 
Information Technology (IT) specialist make the connec-
tions using the right methods. Additional clinical research 
is then needed to evaluate the output and algorithm changes.
Beneficence
Clinical Scenario
Tom would like the provided advice to fit his needs, which 
it does not. The OHCP disagrees with parts of the ML-DST 
output. However, the ML-DST was developed using state of 
the art techniques to provide the best available, valid options 
for possible interventions for Tom. What benefits Tom most?
Issues Discussed: Validity, Evidence Based Practice
To address the principle of beneficence, the OHCP aims 
to support workers in their sustainable ability with “the 
conscientious, explicit, and judicious use of current best 
evidence in making decisions about the care of individual 
patients” [27]. Interaction with the new ML-DST technique 
brings insecurity to the decision making process. Although 
the technical approaches might improve, people may expe-
rience them differently, which influences the value of 
beneficence. Evidence-based medicine is applied through 
integration of best research evidence with clinical expertise 
and patient values [27]. With the introduction of the new 
ML technology, the principle of evidence based medicine 
remains, but the three elements change. First, the research 
evidence changes. Compared to traditional WHAs, applica-
tion of an automated WHA based on ML has great potential 
to advance prevention efforts and foster healthy habits [35]. 
But the ML-DST advice strongly depends on the validity 
of the algorithm and recommended results. As outlined in 
the paragraph about respect for autonomy, there are cur-
rently reasons for a critical stance towards the validity of 
ML-DST algorithms, needing interdisciplinary collaboration 
and a critical approach to development of the DST and to 
maintaining protecting integrity of the database. Secondly, 
the clinical expertise changes. Professional competence is 
built on knowledge, experience with former clients, clinical 
reasoning, communication and decision making [36]. The 
OHCP is constantly learning and adjusting, comparing 
options using an autonomous internal neural network. This 
same learning process is implemented in the development 
ML-DST, so in theory ML-DSTs may be trained to learn, 
develop, and make decisions like a competent and successful 
OHCP. However, a main difference between the “internal 
network of an OHCP” and the ML-DST network is that the 
advice of an ML-DST now informs and influences OHCP 
decisions, with unknown consequences. The third and last 
element that changes are patient values. Trust is a precondi-
tion for beneficence. The way the worker values the advice 
received relates to the trustworthiness of the professional 
[34, 37]. How can the worker trust the ML-DST or the 
OHCP when the results cannot be explained? Generally, 
there is a lack of understanding about ML techniques among 
OHCPs and their clients (workers), which can be an obstacle 
to trust in decisions informed by ML algorithms [34]. It is 
important that results are interpreted in the context of all 
available evidence, which also implicates knowledge about 
the ML algorithm development [22].
Consequences and Directions for Stakeholders 
and Development
A better knowledge and understanding of the OHCP related 
to ML-DSTs could improve trust in the ML-DST with benef-
icence as a consequence. The OCHP relying on the results 
of the ML-DST should be familiar with the choices made in 
advance and their consequences, then take them into account 
in the interpretation to provide a judicious decision [34]. 
This requires epistemological knowledge about the ML-DST 
as well as a critical and reflective appraisal of the tradition-
ally acquired clinical knowledge of the professional. It is 
also important the OHCP is able to explain the decisions 
and the process to the worker. The required new knowledge 
and different skills give new meaning to the professional 
role [22, 38, 39].
Non‑maleficence
Clinical Scenario
Tom is afraid that his data will be shared with third parties 
against his will. He is worried that the OHCP will share 
results with his employer who might judge him as unfit for 
his job. He is also afraid the data and results will be shared 
with insurance companies and have a negative impact on his 
health insurance premium.
 Journal of Occupational Rehabilitation
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Issues Discussed: Context, Function Creep, Privacy, 
Custodianship and Ownership
The occupational context for developing and using an ML-
DST brings great opportunities as well as considerations 
and complications from an ethical perspective. [20] Many 
stakeholders with often conflicting priorities are involved: 
e.g., the employer, the employees, regulations, the OHCP, 
software-developers, researchers and insurance companies. 
Although all intentions might be good, they often have dif-
ferent interests and perspectives. An important consideration 
for this setting is the vulnerability of the worker and the 
potential harm an ML-DST may cause [20, 28].
The use of techniques for unforeseen and different pur-
poses than the developers aimed for is called function creep 
[5]. When personal data are involved, privacy becomes an 
issue and misuse might bring harm. In case of the ML-
DST for a WHA, the tool might be used for exclusion of 
workers, based on pre-assumptions about the health risks 
that will be revealed. This is shown in our scenario where 
Tom is afraid to lose his job. Local law, regulations, codes 
and rules of conduct should bring clarity and help ensure 
patient privacy is protected. However, due to technological 
and societal developments, these privacy rights have become 
ambiguous. Examples of unforeseen use of data are already 
available. Mendelson et al. [40] described an Australian 
situation where health records were co-linked lawfully with 
new technology, but the result was that third parties could 
access individual’s health information without the patient’s 
knowledge or consent [40]. Even in a closed environment 
without sharing of databases, the custodianship and owner-
ship of data might become blurred. In our scenario, people 
who change jobs or stop working remain in the database and 
it is difficult to delete their information from the database if 
requested [41]. This becomes even more challenging when 
data originate from different companies. These examples of 
function creep with health data show how important it is that 
we are aware and that we have to reflect on how we value 
privacy, custodianship and ownership of data.
The risk of individual harm and the right to privacy, 
custodianship and ownership of personal data should be 
balanced with the potential benefits for the group when 
data are shared. It might be argued that the improvement 
of health on a group-level should outweigh how we value 
privacy in relation to autonomy for an individual. This is in 
line with the societal movement of the choice for openness 
and sharing of data [21, 22]. A profound development has 
been the public’s willingness to share personal information 
in a variety of public venues (e.g., social media, wearable 
devices and health apps). Furthermore, many societies (e.g. 
United States of America, China, European Union) have 
embraced ‘big data’ research for health science in parallel 
to the increasing transparency and public accountability that 
governments are moving towards [22].
Consequences and Directions for Stakeholders 
and Development
A realistic concern is group-level harm or individual harm in 
case of function creep, because the workers are vulnerable in 
relation to their employer. In our opinion, it is a responsibil-
ity of the developers to take this into account when develop-
ing ML-DSTs. It is also a responsibility of users to respect 
integrity and balance the risk of harm for an individual with 
the potential beneficence for the group. The privacy, cus-
todianship and ownership issues do not uniquely apply to 
our scenario, because the sharing of personal information 
is more integrated into our daily lives than we are aware 
of, through the application of technology. It is critically 
important to sufficiently consider the consequences for our 
freedom, and carefully consider the consequences to non-
maleficence, autonomy and justice.
Justice
Clinical Scenario
Tom is afraid that the results of his WHA and the matching 
advice will compromise his position at the company and 
maybe even his options for health insurance. Besides, the 
profile that was created was not congruent with his own 
image of his essential health issues and he didn’t feel recog-
nized as a person. Tom is afraid that workers with the same 
constitution (e.g. gender, age, weight, vitality) who did not 
attend the assessment will be favoured over him.
Issues Discussed: Profiling, Discrimination and Conflict 
of Interest on the Part of OHCPs/Companies
The models created and used by ML-DSTs lead to profiles 
of workers for whom an intervention could be successful. 
This is inherent to the main goal of the ML-DST: to iden-
tify patterns and build classifications from available person 
characteristics, health services information, as well as work-
related and health outcomes. ML techniques theoretically 
provide objective results, free of prejudice about the person, 
to render equitable recommendations. However, beyond the 
validity of the classifications, workers may have unique char-
acteristics that are difficult to measure and include in data-
bases, causing bias as a result of omitted variables. Ques-
tions may arise as to whether the ML-DST process does 
justice to the individuals being profiled as members of a 
category that is separate from the individual’s unique iden-
tity [42]. The phenomenon is not different from issues that 
arise from applying classical clinical practice guidelines, 
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but the perception might be different when the ML-DST is 
presented as “personalized” [42]. On the other side of the 
spectrum, when profiling becomes very detailed and many 
variables are used for identification, anonymity might be at 
risk. The right to privacy as the right not to share informa-
tion was already addressed. Here the consequences of being 
recognized at the expense of equal treatment is explored. 
Several studies have highlighted that the techniques for ML 
have reached a level of sophistication that makes it impos-
sible to promise perfect anonymity, even when data are 
depersonalized [22, 23, 42]. These risks apply particularly 
when data used in analyses are from open sources [22], such 
as social media, device location, sports apps. For an occu-
pational context with identifiable parameters such as job, 
task or years employed, this might also be a major risk. In 
this case, Tom is afraid for his position at the company and 
being discriminated against in favor of colleagues who did 
not participate in the assessment.
Another problem with group profiling is that the ML-DST 
for sustained employability could be used for discrimination 
[28]. For example, by excluding people from work on the 
group-level [22] when recommended interventions are not 
cost-effective. Profiling and discrimination might put people 
into different positions leading to social and potentially even 
economic inequality, which detriments judicious treatment. 
Even the possibility that this could happen might create a 
feeling of insecurity among workers, as shown in the exam-
ple of Tom. This would affect how the worker behaves and 
therefore also affect his autonomy, the first value that was 
discussed.
Although the risks of denying an individual’s identity, 
the possibility of discrimination, and detailed profiling are 
also possibilities with care-as-usual situations, the theoreti-
cal performance capabilities of ML techniques increase the 
chance it might actually happen. Mittelstadt and Floridi [42] 
and Lipworth et al. [22] have identified this increased risk 
of misuse as a reason for users to value advice provided by 
ML-DSTs differently [22, 42] than traditionally generated 
advice from OHCPs. The profiling might influence the inter-
pretation and decisions of the OHCP and negatively affect 
the relationship between the OHCP and the worker.
Consequences and Directions for Stakeholders 
and Development
The potential benefits for workers from using ML-DSTs in 
occupational health are evident and the objectivity of the 
tools may actually increase the likelihood of equal treatment 
without prejudice. However, this reasoning only counts if the 
profiles actually represent the person correctly. Researchers 
and users of ML-DSTs should take joint responsibility to 
ensure that profiles will not lead to discrimination of indi-
viduals, however this may lead to lower predictive values of 
the ML-DST. The issues related to profiling and potential 
for discrimination should also be formally evaluated when 
Health Research Ethical Committees assess research appli-
cations [23].
Discussion and Implications
We deliberated the ethical implications of using an ML-DST 
in occupational health care by reflecting on the principles 
of respect for autonomy, beneficence, non-maleficence and 
justice [8]. Questions arose that affect both client and pro-
fessional values, leading to important ethical dilemmas for 
this area of practice. One major characteristic of an ethical 
dilemma is when two opposing values or principles occur 
at the same time: both are ideals we pursue but cannot ulti-
mately reach [8, 43]. For example: what if the outcome rec-
ommended by the ML-DST is objectively beneficial for the 
worker, but the worker chooses not to follow the advice? Not 
all of the dilemmas are a direct result of using the technol-
ogy, but we explored how the technology might influence 
values and dilemmas. In line with this, issues we explored 
often relate to more than one ethical principle. For instance, 
discrimination affects a fair opportunity for people, affect-
ing the principle of justice. However, it can also do harm 
when pre-assumptions about health result in exclusion from 
job tasks, affecting the principle of non-maleficence. This 
paper does not address how to deal with dilemmas but gives 
insight into what might happen and how to anticipate them.
Technical, methodological and epistemological aspects of 
the ML technique and the decisions made for development 
appear to have ethical implications. It is out of scope of this 
manuscript to give detailed directions for ML techniques 
and methodology for development and validation of DSTs. 
Instead we recommend considering the impact and poten-
tial adverse effects of the ML-DST at different phases of 
the innovation process, incorporating input from multiple 
disciplines for a socially responsible design.
Although our aim was to explore emerging universal ethi-
cal issues of using an ML-DST in the occupational context, 
subjectivity could not be avoided because values are not con-
sistent across all cultures. As Ebbesen et al. [43] point out, 
there are reasons to assume that the values as formulated by 
Beauchamp and Childress [8] do not reflect universal moral-
ity, but the characteristics of North American society. We 
chose this classification because it is most commonly used 
in the biomedical context and, according to Beauchamp and 
Childress, it reflects common morality beyond the medical 
world including the occupational context. Another culture-
specific classification might bring other ethical issues and 
dilemmas to light.
Summarizing the consequences and directions for 
stakeholders that were discussed in the results, three 
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recommendations for future ML-DST development arise. 
Although this cannot fully prevent unforeseen ethical issues, 
applying this advice should contribute to minimizing unde-
sirable adverse effects.
– The first recommendation is the importance of ‘edu-
cating’ the ML-DST well by providing it with the best 
available data, training it with the best available algo-
rithms, validating the ML-DST, and discussing its ethical 
impact. Including input from all relevant stakeholders 
during development and implementation (e.g., health 
care professionals, IT specialists, employees, employers, 
researchers) will assist in considering the possible impact 
and side effects. This will enable socially responsible 
design and a valid and ethically-accepted ML-DST, while 
minimizing risk of function creep.
– Secondly, ML-DST research applications should be for-
mally assessed by Health Research Ethical Committees 
for the risk of potential profiling, function creep, discrim-
ination as well as issues around privacy, custodianship 
and ownership of the data and the new tools developed. 
To our knowledge this is a new domain for Research Eth-
ics Committees, therefore awareness and new approval 
and oversight procedures are likely required. Considera-
tions should be specific to individual occupational set-
tings where the studies are being conducted.
– Thirdly, OHCPs should be educated about the epistemol-
ogy of the ML-DST and their strengths and weaknesses 
to enable conscientious, explicit, and judicious use of 
current best evidence in making decisions about the care 
of individual patients while being informed by these new 
potentially beneficial techniques [27].
These recommendations arose from our example of a 
workers’ health assessment, but likely also apply to other 
occupational health-related activities were ML-DSTs are 
introduced and the evidence based practice will be informed 
by these techniques. To continue the necessary, trustful 
relationships with clients it is an essential prerequisites that 
users (OHCPs) are educated and ethical values are balanced 
and protected by all stakeholders.
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